ABC: The Health Report, Monday 27 July 2015 5:50PM For people diagnosed with HIV, an effective vaccine is something of a holy grail. It would allow serodiscordant couples to manage the possibility of transmission, and improve outcomes for millions of HIV-positive cases, many of which are in sub-Saharan Africa. Vaccines have been tried before: two different HIV vaccines were tested in Thailand...
Hi SASHA readers,
Some people have pointed out that the link in the previous post “Depo-Provera Linked to Increased HIV Risk in Africa” goes to a login page which locks them out. I found the article through google, and it turns out you can only access it in you go in that way, i.e. via google results. I was not aware of this when i posted it.
Cheers,
SASHA
Medscape, January 09, 2015
The injectable contraceptive depot medroxyprogesterone (Depo-Provera or DMPA) is associated with elevated risk for HIV infection among women in low-income or middle-income countries of sub-Saharan Africa, according to a study.
The mechanism behind a link between DMPA and HIV infection is not known.
Read more here